A Study of Paliperidone Palmitate 6-Month Formulation
Condition: Schizophrenia Interventions: Drug: PP6M 700 mg eq.; Drug: PP6M 1000 mg eq.; Drug: PP3M 350 mg eq.; Drug: PP3M 525 mg eq.; Drug: PP1M; Other: Placebo Sponsor: Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials